← Back to headlines
Novo Nordisk Stock Rises Over 30% Since March, Linked to Weight-Loss Pill Sales
Novo Nordisk's stock has surged more than 30% since March, with economists attributing the momentum to strong sales of its weight-loss medications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
